Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Regis Hits Switch On Potent Compounds

by Rick Mullin
September 7, 2015 | A version of this story appeared in Volume 93, Issue 35

[+]Enlarge
Credit: Regis
An isolator in Regis’s new potent compound suite.
Photo of a man wearing a potent compound suite, as he reaches in an isolator.
Credit: Regis
An isolator in Regis’s new potent compound suite.

Regis Technologies is entering the oncology drug active ingredient market with the start-up of a potent compound manufacturing suite at its plant in Morton Grove, Ill. The contract manufacturer says the suite includes isolators, laminar flow hoods, and other protective technologies to facilitate small-molecule and antibody-drug conjugate projects.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.